infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who were clinically diagnosed or highly suspected infection; 2. Temperature>38.5 degree C; 3. Patients who had not recieved anti-infection treatment or still had repeated fever after using anti-infection scheme; 4. All subjects included should fully understand the clinical trial and sign a consent form.
Exclusion criteria
Exclusion criteria: 1. Subjects with fever caused by acute rejection or drug allergy; 2. Subjects with clear surgical complications like leaky gut, bile leakage and so on; 3. Subjects with severe coagulation disorder, hematological system diseases or in a critical condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CMV-IgM;CMV-DNA;Deep fungus antigen;Blood culture;Phlegm culture;Bile culture;Urine culture;Defecate culture;Abdominal drainage fluid culture;The end of a deep vein intubation culture; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood routine examination;Yeast glucan;Procalcitonin; | — |
Countries
China